Background Acute respiratory failure is the main cause of admission to intensive care unit in
immunocompromised patients. In this subset of patients, the beneficial effects of noninvasive …

BACKGROUND: Various studies have been performed to examine the effect of high-flow
nasal cannula (HFNC) in immunocompromised patients with acute respiratory failure (ARF) …

Aim To identify which subgroups of respiratory failure could benefit more from high‐flow
nasal cannula oxygen therapy (HFNC) or non‐invasive ventilation (NIV). Methods We …

Background Although non-invasive ventilation (NIV) is recommended for
immunocompromised patients with acute respiratory failure in the intensive care unit (ICU), it …

Objective: In immunocompromised patients with acute respiratory failure, invasive
mechanical ventilation remains associated with high mortality. Choosing the adequate …

Background The use of non-invasive ventilation is controversial in immunocompromised
patients with acute respiratory failure, whereas the use of high-flow nasal cannula oxygen …

Purpose Acute respiratory failure remains a common hazardous complication in
immunocompromised patients and is associated with increased mortality rates when …

Introduction To evaluate the efficacy of high-flow nasal cannula (HFNC) in the rate of
intubation and mortality for patients with acute hypoxemic respiratory failure. Methods We …

We reviewed the use of noninvasive ventilation (NIV) versus high flow nasal cannula
(HFNC) oxygen in adult acute respiratory failure (ARF). We searched major databases and …

Background High-flow nasal cannula oxygen (HFNC) is a relatively new therapy used in
adults with respiratory failure. Whether it is superior to conventional oxygen therapy (COT) or …